Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Ditsch

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Journal of Cancer Research and Clinical Oncology|May 30, 2020
Expression of H3K4me3 and H3K9ac in breast cancerLuisa Berger, Thomas Kolben, Sarah Meister, et al.
Journal of Reproductive Immunology|April 20, 2023
The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patientsJohanna Mittelberger, Marina Seefried, Sanja Löb, et al.
International Journal of Molecular Sciences|January 24, 2019
Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary reportKatharina Müller, Sophie Sixou, Christina Kuhn, et al.
Journal of Translational Medicine|February 23, 2020
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancersWanting Shao, Christina Kuhn, Doris Mayr, et al.
Cells|April 12, 2022
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer PatientsWanting Shao, Melitta B Köpke, Theresa Vilsmaier, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Oncology Letters|December 4, 2012
Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinomaNina Ditsch, Doris Mayr, Miriam Lenhard, et al.
International Journal of Molecular Sciences|January 18, 2020
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast CancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
International Journal of Molecular Sciences|March 10, 2022
Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian CancerSabine Heublein, Udo Jeschke, Cornelia Sattler, et al.
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Journal of Cancer Research and Clinical Oncology|May 30, 2020
Expression of H3K4me3 and H3K9ac in breast cancerLuisa Berger, Thomas Kolben, Sarah Meister, et al.
Journal of Reproductive Immunology|April 20, 2023
The programmed cell death protein 1 (PD1) and the programmed cell death ligand 1 (PD-L1) are significantly downregulated on macrophages and Hofbauer cells in the placenta of preeclampsia patientsJohanna Mittelberger, Marina Seefried, Sanja Löb, et al.
International Journal of Molecular Sciences|January 24, 2019
Prognostic relevance of RIP140 and ERβ expression in unifocal versus multifocal breast cancers: a preliminary reportKatharina Müller, Sophie Sixou, Christina Kuhn, et al.
Journal of Translational Medicine|February 23, 2020
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancersWanting Shao, Christina Kuhn, Doris Mayr, et al.
Cells|April 12, 2022
Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer PatientsWanting Shao, Melitta B Köpke, Theresa Vilsmaier, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Correction to: Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Oncology Letters|December 4, 2012
Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinomaNina Ditsch, Doris Mayr, Miriam Lenhard, et al.
International Journal of Molecular Sciences|January 18, 2020
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor β1 Are Inversely Associated with Survival in Primary Breast CancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
International Journal of Molecular Sciences|March 10, 2022
Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian CancerSabine Heublein, Udo Jeschke, Cornelia Sattler, et al.
Pageof 21